Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Aug 14, 2012; 18(30): 3923-3930
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.3923
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.3923
Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers
Dong-Xing Cao, Zhi-Jie Li, Xiao-Ou Jiang, Yick Liang Lum, Ester Khin, John M Luk, Department of Pharmacology and Department of Surgery, National University Health System, National University of Singapore, Singapore 117597, Singapore
Dong-Xing Cao, Guo-Hao Wu, Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Zhi-Jie Li, John M Luk, Department of Oncology, Roche R and D Center (China) Ltd., Shanghai 201203, China
Nikki P Lee, John M Luk, Department of Surgery, The University of Hong Kong, Hong Kong, China
Author contributions: Cao DX and Li ZJ wrote the manuscript; Jiang XO, Lum YL and Khin E collected the relevant references and provided materials; and Lee NP, Wu GH and Luk JM drew the figures and revised the manuscript.
Correspondence to: John M Luk, Professor, Department of Oncology, Roche R and D Center (China) Ltd., 720 Cai Lun Road, Shanghai 201203, China. john.luk@roche.com
Telephone: +86-21-38954910 Fax: +86-21-50790293
Received: February 11, 2012
Revised: May 11, 2012
Accepted: May 26, 2012
Published online: August 14, 2012
Revised: May 11, 2012
Accepted: May 26, 2012
Published online: August 14, 2012
Core Tip